Scilex Holding SCLX
NASDAQ SCLX
$5.67 -0.13 (-2.20%)
As of: Aug 21, 2026 · 1:38 PM EDT

Scilex Holding (SCLX) Gross Margin (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Gross Margin of 48.29% for Q1 2026, down 2403.0% year-over-year from 2.1% in Q1 2025, and up 5.0% quarter-over-quarter from 45.99% in Q4 2025.

Scilex Holding (SCLX) Gross Margin (2022 - 2026) Analysis & Trends

Scilex Holding's Gross Margin history runs 5 years deep, the most recent figure standing at 48.29% for Q1 2026.

  • In Q1 2026, Gross Margin fell 2403.0% year-over-year to 48.29%; the TTM figure through Mar 2026 stood at 59.69% (down 1224.0% YoY), while the FY2025 annual figure was 65.02%, down 549.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 48.29%, up from 45.99% in the prior quarter.
  • The five-year high for Gross Margin was 83.21% in Q1 2022, with the low at 45.99% in Q4 2025.
  • The 5-year median for Gross Margin is 66.94% (2025), against an average of 67.2%.
  • The sharpest annual moves came in 2025 and 2026: Gross Margin soared 760 bps in 2025, then tumbled 2403 bps in 2026.
  • Scilex Holding's Gross Margin stood at 62.14% in 2022, then climbed by 7 bps to 66.42% in 2023, then grew by 3 bps to 68.54% in 2024, then sank by 33 bps to 45.99% in 2025, then gained by 5 bps to 48.29% in 2026.
  • Business Quant data shows SCLX's Gross Margin at 48.29% in Q1 2026, 45.99% in Q4 2025, and 68.48% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 653.37 Bn 632.61 Bn 17.26 Bn 68.19%
2 AbbVie 469.65 Bn 463.08 Bn 12.70 Bn 74.74%
3 Merck 376.13 Bn 368.99 Bn 12.21 Bn 73.54%
4 Novartis Ag 303.28 Bn 295.59 Bn 11.24 Bn 78.02%
5 Astrazeneca 258.06 Bn 253.16 Bn 12.86 Bn 83.60%
6 Amgen 236.35 Bn 222.36 Bn 7.24 Bn 72.04%
7 Gilead Sciences 182.15 Bn 178.97 Bn 6.22 Bn 79.76%
8 Pfizer 159.57 Bn 147.87 Bn 10.94 Bn 72.78%
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 73.05%
10 Scilex Holding 39.10 Mn -73.69 Mn 3.97 Mn 51.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 48.29%
Dec 31, 2025 45.99%
Sep 30, 2025 68.48%
Jun 30, 2025 66.94%
Mar 31, 2025 72.32%
Dec 31, 2024 68.54%
Sep 30, 2024 73.90%
Jun 30, 2024 73.18%
Mar 31, 2024 64.72%
Dec 31, 2023 66.42%
Sep 30, 2023 66.47%
Jun 30, 2023 66.80%
Mar 31, 2023 66.07%
Dec 31, 2022 62.14%
Sep 30, 2022 68.26%
Jun 30, 2022 80.71%
Mar 31, 2022 83.21%